Comparison of cholinesterase inhibitor safety in real‐world practice-Reference-Cited by-同舟云学术

Comparison of cholinesterase inhibitor safety in real‐world practice

Published:2019-01 Issue:1 Volume:5 Page:732-739
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Carney Greg¹²,Bassett Ken¹²³,Wright James M.¹²⁴,Maclure Malcolm¹²,McGuire Nicolette⁵,Dormuth Colin R.¹²

Affiliation:

1. Therapeutics InitiativeUniversity of British ColumbiaVancouverBCCanada

2. Department of Anesthesiology, Pharmacology and TherapeuticsUniversity of British ColumbiaVancouverBCCanada

3. Department of Family PracticeUniversity of British ColumbiaVancouverBCCanada

4. Department of MedicineUniversity of British ColumbiaVancouverBCCanada

5. Research and Innovation Division, B.C. Ministry of HealthVictoriaBCCanada

Funder

University of British Columbia

Ministry of Health

British Columbia Ministry of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2019.09.011

Reference27 articles.

1. Changes to PharmaCare Coverage for Cholinesterase Inhibitors. April 2016.http://www2.gov.bc.ca/assets/gov/health/health‐drug‐coverage/pharmacare/adti‐health‐professional‐infosheet.pdfAccessed October 21 2019.

2. Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease

3. A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease

4. Guidelines for the Management of Cognitive and Behavioral Problems in Dementia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indole alkaloids from Ochreinauclea maingayi (Rubiaceae) as butyrylcholinesterase inhibitors and their paralysis effect in transgenic Caenorhabditis elegans;Natural Product Research;2024-08-21

2. A review of the advances, insights, and prospects of gene therapy for Alzheimer’s disease: A novel target for therapeutic medicine;Gene;2024-06

3. Acetylcholinesterase inhibition activity and phytochemical screening of red betel leaf (Piper crocatum Ruiz & Pav) as anti-dementia agents;BIO Web of Conferences;2024

4. Indole Alkaloids from Ochreinauclea Maingayi (Rubiaceae) as Butyrylcholinesterase Inhibitors and Their Paralysis Effect in Transgenic Caenorhabditis Elegans;2024

5. Application of Marine Natural Products against Alzheimer’s Disease: Past, Present and Future;Marine Drugs;2023-01-05